As of November 30, 2025, no fertility clinic is routinely offering IVF using human egg cells derived from a patient’s somatic cells (e.g., skin cells) via in‑vitro gametogenesis (IVG) in clinical practice. Research groups have generated functional egg and sperm cells from somatic or pluripotent cells in mice and other animals, and human IVG has advanced in vitro (e.g., creating primordial germ cell–like cells and early gamete precursors), but no approved, routine clinical IVF protocol exists yet for producing fully functional human eggs from skin cells and using them in patients.

However, the normalized prediction is explicitly about what will be routine "by roughly the late 2020s". The current date is still only 2025, so the time window for the prediction (late 2020s ≈ 2027–2029) has not arrived. Because we cannot yet observe whether this will become routine by that future period, the correctness of the prediction cannot be determined at this time.

Therefore, the appropriate status is: it is too early to tell whether his forecast about late‑2020s routine clinic use will prove right or wrong.